Avantor announces investment in manufacturing and distribution hub in Singapore
With this, the company intends to serve the rapidly-growing Asia Pacific biopharma industry
Avantor today announced that it will create a new manufacturing and distribution hub in Singapore, by integrating its existing distribution facility with new manufacturing operations. The new hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early next year, the company notified in a statement.
The statement noted that the new hub will provide a range of services including quality control and inventory management expertise, and feature cGMP manufacturing suites and testing labs for process ingredients and excipients.
“The Singapore Manufacturing and Distribution Hub will enable Avantor to better serve the fast-growing Asia Pacific Biopharma market by facilitating shorter lead times, enhancing supply chain security and increasing capacity in the region. The hub will boost regional innovation and serve as an industry benchmark for Singapore and Asia Pacific’s global quality and regulatory standards, and demonstrates Avantor’s commitment to growing our presence in the region,” said Christophe Couturier, Executive Vice President, AMEA, Avantor, in the statement.